Source: Guident Ltd, Vira Mylyan-Monastyrska and Ibnu Alias / Shutterstock.com
UK intellectual property investment group,has announced that their portfolio company Guident has licensed an exclusive patent in the United States titled “Remote Control and Concierge Service for an Autonomous Transit Vehicle Fleet”.
The patent covers methods for remote control centers to assist autonomous vehicles and drones via the machines’ sensor inputs, enabling the control centers to aid in “difficult situations,” such as extreme weather.
The overall aim is to increase not only driver safety but also driver confidence in these new-wave vehicles.
A recent survey by PWC found that 43% of respondents said they believed autonomous vehicles were at a disadvantage when it came to safety compared to their traditional counterparts.
Dr. Clifford Gross, Tekcapital’s Chairman, commented:
“We are delighted to see that Guident has exclusively acquired additional intellectual property rights to enhance the adoption and utilization of AV's. We believe that autonomous vehicles and drones will help democratize transportation and delivery.
However, to enhance the safety and practicality of AV's, a back-up control centre, on stand-by, would enhance consumer confidence that unpredictable situations such as accidents and last mile package delivery mishaps can be handled properly in real-time. This would mind the gap in the foreseeable future between the vision of level 5 autonomy and the stubborn current reality of imperfect artificial intelligence."
Today’s news adds to a very busy week for Tekcapital.
Yesterday, the company shared with investors that its portfolio company Belluscura, which develops a patented portable oxygen concentrator for those who live with COPD, had received commitments for £725,000 of additional funding at 15p per share.
Additionally, the company expressed it is confident that Belluscura will receive FDA clearance later this year, which would open the door for a commercial launch in H1 2020.
Tekcapital’s foothold, through its portfolio companies, in attention-grabbing markets doesn’t end with autonomous vehicles and biotech solutions; they’re also working on a low-sodium salt at Salarius and next-gen eyewear at Lucyd.
For more news and updates on Tekcapital:
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
“We are extremely pleased to address another market with our first oncology test which has already seen traction in the UK and Europe since its launch in September 2019, and reinforces our strategic plans of product penetration and geographic expansion,” said Lyn Rees, Chief Executive of Yourgene.
Boris Johnson's new cabinet will meet for the first time later, following a reshuffle that saw Sajid Javid quit his role as chancellor. The prime minister had offered to reappoint Mr Javid on the condition he fire his team of aides a demand rejected by Mr Javid which means Rishi Sunak, former chief secretary to the Treasury, has been appointed as the new Chancellor.